• Home
  • Disease & Drugs
  • Wellness
  • Health Tidings
  • Whitepapers
  • Newsletter
  • About
  • Home
  • Disease & Drugs
  • Wellness
  • Health Tidings
  • Whitepapers
  • Newsletter
  • About
  • Home
  • Disease & Drugs
  • Wellness
  • Health Tidings
  • Whitepapers
  • Newsletter
  • About

Home

Monthly Archives: July 2025

Gene

FDA Halts Sarepta Therapeutics’ AAVrh74 based Gene Therapy Trials after Third Death from Liver Failure

July 22, 2025
by official.ajinkya11@gmail.com Clinical Trails

19 July 2025Category: Drug Safety Alert / Gene Therapy Safety UpdateWritten by: Pharmacally Medical News Desk Sarepta Therapeutics has been developing investigational gene therapies based on AAVrh74 vector technology for ...

Read More
0
ChatGPT Image Jul 20, 2025, 02_01_12 PM

“Repurposing Fenbendazole in Oncology: Hype vs. Hope in the Context of the ‘Joe Tippens Protocol'”

July 22, 2025
by official.ajinkya11@gmail.com Research

20 July 2025Category: Drug Repurposing & Experimental Therapies IOncology Trends & Public PerceptionMedically Reviewed By: Dr. Htet Wai Moe (MBBS, MD-Pharmacology, PhD-Pharmacology)Defence Services Medical Research Centre, Naypyitaw, Myanmar ...

Read More
0
2149639222

Topline Phase 3 Results of Hengrui Pharma and Kailera Therapeutics’ Dual Agonist HRS9531 Shows Promising Weight Loss: A Rising Competitor to Zepbound?

July 22, 2025
by official.ajinkya11@gmail.com Health Tidings

19 July 2025Category: Clinical Trials & Drug Development IObesity & Metabolic DisordersWritten by: Pharmacally Medical News Desk In a key event, Chinese pharmaceutical giant Hengrui Pharma and U.S.-based biotech ...

Read More
0
18924

“FDA raises Ocular Toxicity Concerns over GSK’s Blenrep (Belantamab Mafodotin): A Setback for Multiple Myeloma Hope”

July 21, 2025
by official.ajinkya11@gmail.com Clinical Trails

17 July 2025Article updated on 17 July 2025 after ODAC meetingCategory: Drug Safety & Regulatory Affairs I Adverse Events & Warnings IOncology Drug SafetyWritten by: Pharmacally Medical News Desk The U.S. Food an ...

Read More
0
2149152754

Sun Pharma Launches LEQSELVI™ in the U.S. for Severe Alopecia Areata after Patent Settlement

July 21, 2025
by official.ajinkya11@gmail.com New Drug Approval

16 July 2025Category: New Drug Approval I DermatologyIAlopecia Areata TreatmentWritten By: Pharmacally Medical News Desk India’s Sun Pharmaceutical Industries Ltd., one of the world’s largest specialty generics pharmaceu ...

Read More
0
hand-with-medication-dark-style (1)_11zon

CDSCO Issues Advisory on Flushing 17 Expired Drugs: A Crucial Step for Public Health and Safety

July 13, 2025
by official.ajinkya11@gmail.com Health Tidings

13 July 2025Category: Drug Regulation and Public Health Policy IDrug Safety & Disposal I Pharmaceutical Waste ManagementWritten By:Pharmacally Medical News Desk Source: Freepik.com "In past instances, w ...

Read More
0
Health Benefits of Ghee in Ayurveda

“Benefits of Ghee (Clarified Butter) in Ayurveda: Nourishment for Body, Mind, and Spirit”

July 11, 2025
by official.ajinkya11@gmail.com Food

11 July 2025Category: Ayurveda & Traditional Medicine I Healthy Fats & Oils IHealth & Wellness Written By:Vedanti More (PharmD)Reviewed By:AyurvedacharyaDr. Gaurav Pathare (BAMS) "शस्तं धीस्मृततमधातिबलायुुःशु ...

Read More
0
ChatGPT Image Jul 9, 2025, 07_56_43 PM

Alphabet’s Inc. subsidiary Isomorphic Labs Initiates Human Trials of First AI-Designed Drug: the Beginning of a New Era in Precision Therapeutics

July 9, 2025
by official.ajinkya11@gmail.com Health Tidings

09 July 2025Category: Drug Discovery and Development IAI in Drug DevelopmentWritten By: Pharmacally Medical News Desk Isomorphic Labs, a wholly owned subsidiary of Alphabet Inc., has announced the commencement of human t ...

Read More
0
ChatGPT Image Jul 8, 2025, 11_56_42 PM

Novartis’s First-ever Malaria Treatment for Newborns under 5 kg- Coartem® Baby Approved by Swissmedic

July 8, 2025
by official.ajinkya11@gmail.com New Drug Approval

08 July 2025Category: Drug Approvals & Regulatory Updates IInfectious Diseases – Malaria & Public Health ImpactWritten By: Pharmacally Medical News Desk In a landmark decision on July 8, 2025, Swissmedic approved ...

Read More
0
sleepreview

Can the Weight Loss Indication of Semaglutide and Tirzepatide Be Revoked in India? Understanding the Recent PIL against GLP-1 Drugs

July 8, 2025
by official.ajinkya11@gmail.com Disease & DrugsHealth Tidings

08 July 2025Category: Drug Safety & RegulationWritten by:Pharmacally Medical News Desk Source:sleepreviewmag.com A recent Public Interest Litigation (PIL) filed by Jitendra Chouksey, founder of FITTR, i ...

Read More
0
  • 1
  • 2
  • Next
  • Last

Recent Posts

  • FDA Halts Sarepta Therapeutics’ AAVrh74 based Gene Therapy Trials after Third Death from Liver Failure
  • “Repurposing Fenbendazole in Oncology: Hype vs. Hope in the Context of the ‘Joe Tippens Protocol'”
  • Topline Phase 3 Results of Hengrui Pharma and Kailera Therapeutics’ Dual Agonist HRS9531 Shows Promising Weight Loss: A Rising Competitor to Zepbound?
  • “FDA raises Ocular Toxicity Concerns over GSK’s Blenrep (Belantamab Mafodotin): A Setback for Multiple Myeloma Hope”
  • Sun Pharma Launches LEQSELVI™ in the U.S. for Severe Alopecia Areata after Patent Settlement

Recent Comments

No comments to show.

Archives

  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025

About Us

  • About Us
  • Internship with us
  • Terms and Conditions

Categories

  • Clinical Trails
  • Disease & Drugs
  • Food
  • Health Tidings
  • Lifestyle
  • New Drug Approval
  • Research
  • Wellness
  • Women & Child Health

Pharmacally a brand of

MedCognize Communications (OPC) Pvt. Ltd.

Gat No. 405, Plot No. 17, Post-Nighoje, Near Faith Automation,

Opp. Anjali T Precision, Chakan Industrial Area, Pune 410501

Maharashtra, India

Contact No. - +91 9960598036

Email - contactus@pharmacally.com

  • About Us
  • Advisory Panel (Medical Experts)
  • About Founder
  • Source of Information

Follow Us -

Facebook Whatsapp Linkedin X-twitter
  • Internship with us
  • Advertise with us
  • Privacy Policy
  • Terms & Conditions

Subscribe to Newsletter -

SUBSCRIBE

Follow Us -

Facebook Whatsapp Linkedin X-twitter

Disclaimer: The content provided on the website is for information purposes only and is not intended as medical advice, diagnosis or treatment. Always seek doctors and other health provider’s advice in person regarding your any medical query or condition.

Copyright © 2025 Pharmacally | Designed by TEXPERT MENTOR

Shopping Basket